About
Leica Biosystems is a global leader in medical devices, focusing on cancer diagnostics and pathology workflow solutions. Founded in 1872 in Heidelberg, Germany, the company has a rich history of over 150 years and operates in various countries, including the United States, United Kingdom, and China. As a division of Danaher Corporation, Leica Biosystems offers a comprehensive range of products that cover the entire pathology workflow, from biopsy sample preparation to digital pathology and reporting. The company provides integrated solutions that enhance cancer diagnostics and improve patient outcomes. Its product portfolio includes precision instruments like microtomes, staining systems, digital pathology platforms, and tissue imaging services. Leica Biosystems is committed to innovation, particularly in digital pathology and companion diagnostics, and collaborates with leading institutions to advance cancer diagnostics through technology. With a mission of "Advancing Cancer Diagnostics, Improving Lives," the company supports over 1.6 million cancer diagnoses weekly worldwide, serving hospitals, pathology labs, research institutions, and pharmaceutical companies.
Technologies
Keywords
Company Information
-
Employees 3400
-
Founded 1989
-
Annual Revenue $622500000
Location
17-19 Heidelberger Strasse, Nussloch, Baden-Wuerttemberg, Germany, 69226
